Dramatic reduction in tumour size in hepatocellular carcinoma patients on thalidomide therapy, Pulsus Group Inc
       
  Pulsus Group Inc. The Medical Peer Review Publisher
                                                                                                                       
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
 
  Search Canadian Journal of Gastroenterology
Search    
Advanced Search CONSUMER SITE
PROFESSIONAL SITE
 
 
 
 
CANADIAN JOURNAL OF GASTROENTEROLOGY
The Canadian Association of Gastroenterology (CAG) Canadian Association for the Study of the Liver (CASL)
                                                                                   
                                                                                   
                                                                                   
 
   Home   
   Current Issue   
   Past Issues   
   Guidelines   
   Supplements   
   Submit Manuscript   
   Calendar   
   Links   
 
 
 
Return to TOC
   PDF / Free   
 
Images in Hepatology August 2007, Volume 21 Issue 8: 517-518
 
Dramatic reduction in tumour size in hepatocellular carcinoma patients on thalidomide therapy
D Demeria, I Birchall, VG Bain

A 73-year-old man presented with abdominal bloating. His past medical history was significant for peptic ulcer disease with partial gastrectomy, hypertension and a remote smoking history. Investigations included contrast-enhanced computed tomography of the abdomen, which revealed innumerable hypervascular lesions, with early enhancement in the arterial phase. These were larger and more frequent in the right lobe of the liver, although they were also present in the left lobe. Most lesions measured 1.0 cm to 2.0 cm in diameter but there was a dominant lesion measuring 7.0 cm x 4.1 cm (Figure 1) in segments 5 and 8 of the right hepatic lobe. No extrahepatic or nodal metastases were identified. Serum alpha- fetoprotein level was 74.8 µg/L (normal level is less than 9 µg/L). Core biopsy of the liver confirmed multifocal grade II hepatocellular carcinoma.

E-Mail This Abstract To A Colleague
            Click here to download free Adobe PDF Reader
 
 
 
 
  Log in
  Register
  Survey
  Shopping Cart
Copyright © Pulsus Group Inc